Get the latest NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹38.73
▲0.3%1D
NAV as on 24 Jun 2025
21.5%/per year
Since Inception
▲▼
Fund returns vs Benchmark returns vs Category Average returns as on (24-Jun-25)
The fund has consistently outperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.
Calculate SIP and lumpsum returns based on historical performance
Total Investment
0
Profit
Total Corpus
0
See fund asset allocation details as on (14-Jun-25)
Fund Distribution
as on (14-Jun-25)
Equity 97%
Debt & Cash 2.9%
See fund sector allocation details as on (14-Jun-25)
Sector Allocation
Equity 97%
Debt & Cash 2.9%
Top 3 Sectors in May were Health, Basic Materials & Financial Services
Health
95%
Basic Materials
4%
Financial Services
1%
Health
94%
Basic Materials
5%
Financial Services
2%
as on (31-May-25)
Equity
Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.
Expense ratio | 1.9% |
Benchmark | BSE Healthcare TR INR |
AUM | ₹5508 Cr |
Inception Date | 12 July, 2018 |
Min Lumpsum/SIP | ₹5000/₹100 |
Exit Load | 1.0% |
Lock In | No Lock-in |
TurnOver | 49.46% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is an equity fund. This fund was started on 12 July, 2018. The fund is managed by Dharmesh Kakkad. The fund could potentially beat inflation in the long-run.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has given a CAGR return of 21.50% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 20.92%, 29.17% and 24.21% respectively.
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Financial Services. Its top holdings are Sun Pharmaceuticals Industries Ltd, Dr Reddy's Laboratories Ltd, Divi's Laboratories Ltd, Cipla Ltd, Aurobindo Pharma Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 20%For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefitDividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth has no lock in period.
Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth, since 2 May 2020
5Y CAGR
▲ 37.87
5Y CAGR
▲ 33.35
5Y CAGR
▲ 31.19
5Y CAGR
▲ 33.36